Immunohematology Market Size, Share, Trends, Growth Outlook

Immunohematology Market is estimated to increase at a growth rate of 5.3% CAGR over the forecast period from 2024 to 2030.

 

The Immunohematology Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Products (Immunohematology Analyzers, Immunohematology Reagents), By Application (Blood Typing, Antibody Screening), By End-User (Hospitals, Diagnostic Laboratories, Others).

 

An Introduction to Immunohematology Market in 2024

The immunohematology market in 2024 focuses on diagnostic and therapeutic solutions related to blood transfusions and blood compatibility testing. Also known as blood banking or transfusion medicine, immunohematology encompasses the study of blood groups, antibodies, and antigens to ensure safe and compatible blood transfusions. This market includes a range of products such as blood typing reagents, antibody screening and identification tests, and blood banking instrumentation. Immunohematology plays a crucial role in preventing transfusion reactions and managing patients with conditions such as hemolytic disease of the newborn and autoimmune hemolytic anemia. Market growth is driven by factors such as the increasing demand for blood transfusions, advancements in blood banking technologies, and rising awareness about the importance of blood compatibility testing in healthcare settings. Collaboration between blood centers, hospitals, and diagnostic companies fosters innovation in immunohematology, leading to the development of novel reagents, automated testing platforms, and point-of-care solutions that enhance transfusion safety and patient outcomes.

 

Immunohematology Market Trend: Increasing Adoption of Automated Blood Typing Systems

A prominent trend in the Immunohematology market is the increasing adoption of automated blood typing systems. Laboratories and blood banks are transitioning from manual methods to automated platforms for blood typing, crossmatching, and antibody screening. Automated systems offer benefits such as higher throughput, reduced turnaround times, improved accuracy, and enhanced workflow efficiency. As healthcare facilities strive to meet the growing demand for blood products and ensure patient safety, the adoption of automated blood typing systems is expected to continue to rise.

Immunohematology Market Driver: Rising Demand for Blood Transfusions and Blood Products

A significant driver in the Immunohematology market is the rising demand for blood transfusions and blood products. With an increasing number of surgeries, trauma cases, and medical treatments requiring blood transfusions, there is a growing need for compatible blood products to meet patient needs. Immunohematology plays a crucial role in ensuring safe and compatible blood transfusions by identifying blood group antigens and antibodies, performing crossmatches, and preventing transfusion reactions. As the demand for blood products continues to rise globally, the market for immunohematology products and services is expected to grow.

Immunohematology Market Opportunity: Expansion into Emerging Markets and Blood Screening Technologies

An opportunity for market growth in the Immunohematology market lies in the expansion into emerging markets and blood screening technologies. Emerging markets present untapped opportunities for immunohematology products and services, as healthcare infrastructure improves and the demand for blood transfusions increases. Additionally, advancements in blood screening technologies, such as nucleic acid testing (NAT) for infectious disease screening, offer opportunities for innovation and market expansion. By investing in research and development efforts to develop next-generation blood screening technologies and expanding into emerging markets, companies can capitalize on new growth opportunities in the Immunohematology market.

 

Immunohematology Market Segmentation

By Products

Immunohematology Analyzers

Immunohematology Reagents

 

By Application

Blood Typing

Antibody Screening

 

By End-User

Hospitals

Diagnostic Laboratories

Others

 

Geographical Analysis

North America (United States, Canada, Mexico)

Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)

Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

 

Immunohematology Market Companies

Abbott Laboratories

Beckman Coulter Inc (Danaher Corp)

Becton Dickinson and Company

Bio-Rad Laboratories Inc

Cardinal Health

F. Hoffmann La-Roche Ltd

Grifols S.A.

Immucor Inc

Merck KGaA

Ortho Clinical Diagnostics

Siemens Healthineers

Thermo Fisher Scientific

*- List Not Exhaustive

 

Reasons to Buy the Immunohematology Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions

• Gain access to detailed insights on the Immunohematology Market, encompassing current market size, growth trends, and forecasts till 2030.

• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities

• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends

• Identify lucrative investment avenues and expansion opportunities within the Immunohematology Market industry, guided by robust, data-backed analysis.

• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics

• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain

• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics

• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

TABLE OF CONTENTS

 

1 Introduction to 2024 Immunohematology Market

1.1 Market Overview

1.2 Quick Facts

1.3 Scope/Objective of the Study

1.4 Market Definition

1.5 Countries and Regions Analyzed

1.6 Units, Currency, and Conversions

1.7 Industry Value Chain

 

2 Research Methodology

2.1 Market Size Estimation

2.2 Sources and Research Methodology

2.3 Data Triangulation

2.4 Assumptions and Limitations

 

3 Executive Summary

3.1 Global Immunohematology Market Size Outlook, $ Million, 2021 to 2030

3.2 Immunohematology Market Outlook by Type, $ Million, 2021 to 2030

3.3 Immunohematology Market Outlook by Product, $ Million, 2021 to 2030

3.4 Immunohematology Market Outlook by Application, $ Million, 2021 to 2030

3.5 Immunohematology Market Outlook by Key Countries, $ Million, 2021 to 2030

 

4 Market Dynamics

4.1 Key Driving Forces of Immunohematology Market Industry

4.2 Key Market Trends in Immunohematology Market Industry

4.3 Potential Opportunities in Immunohematology Market Industry

4.4 Key Challenges in Immunohematology Market Industry

 

5 Market Factor Analysis

5.1 Competitive Landscape

5.1.1 Global Immunohematology Market Share by Company (%), 2023

5.1.2 Product Offerings by Company

5.2 Porter’s Five Forces Analysis

 

6 Growth Outlook Across Scenarios

6.1 Growth Analysis-Case Scenario Definitions

6.2 Low Growth Scenario Forecasts

6.3 Reference Growth Scenario Forecasts

6.4 High Growth Scenario Forecasts

 

7 Global Immunohematology Market Outlook By Segments

7.1 Immunohematology Market Outlook by Segments

By Products

Immunohematology Analyzers

Immunohematology Reagents

By Application

Blood Typing

Antibody Screening

By End-User

Hospitals

Diagnostic Laboratories

Others

 

8 North America Immunohematology Market Analysis And Outlook To 2030

8.1 Introduction to North America Immunohematology Markets in 2024

8.2 North America Immunohematology Market Size Outlook by Country, 2021-2030

8.2.1 United States

8.2.2 Canada

8.2.3 Mexico

8.3 North America Immunohematology Market size Outlook by Segments, 2021-2030

By Products

Immunohematology Analyzers

Immunohematology Reagents

By Application

Blood Typing

Antibody Screening

By End-User

Hospitals

Diagnostic Laboratories

Others

 

9 Europe Immunohematology Market Analysis And Outlook To 2030

9.1 Introduction to Europe Immunohematology Markets in 2024

9.2 Europe Immunohematology Market Size Outlook by Country, 2021-2030

9.2.1 Germany

9.2.2 France

9.2.3 Spain

9.2.4 United Kingdom

9.2.4 Italy

9.2.5 Russia

9.2.6 Norway

9.2.7 Rest of Europe

9.3 Europe Immunohematology Market Size Outlook By Segments, 2021-2030

By Products

Immunohematology Analyzers

Immunohematology Reagents

By Application

Blood Typing

Antibody Screening

By End-User

Hospitals

Diagnostic Laboratories

Others

 

10 Asia Pacific Immunohematology Market Analysis And Outlook To 2030

10.1 Introduction to Asia Pacific Immunohematology Markets in 2024

10.2 Asia Pacific Immunohematology Market Size Outlook by Country, 2021-2030

10.2.1 China

10.2.2 India

10.2.3 Japan

10.2.4 South Korea

10.2.5 Indonesia

10.2.6 Malaysia

10.2.7 Australia

10.2.8 Rest of Asia Pacific

10.3 Asia Pacific Immunohematology Market size Outlook by Segments, 2021-2030

By Products

Immunohematology Analyzers

Immunohematology Reagents

By Application

Blood Typing

Antibody Screening

By End-User

Hospitals

Diagnostic Laboratories

Others

 

11 South America Immunohematology Market Analysis And Outlook To 2030

11.1 Introduction to South America Immunohematology Markets in 2024

11.2 South America Immunohematology Market Size Outlook by Country, 2021-2030

11.2.1 Brazil

11.2.2 Argentina

11.2.3 Rest of South America

11.3 South America Immunohematology Market size Outlook by Segments, 2021-2030

By Products

Immunohematology Analyzers

Immunohematology Reagents

By Application

Blood Typing

Antibody Screening

By End-User

Hospitals

Diagnostic Laboratories

Others

 

12 Middle East And Africa Immunohematology Market Analysis And Outlook To 2030

12.1 Introduction to Middle East and Africa Immunohematology Markets in 2024

12.2 Middle East and Africa Immunohematology Market Size Outlook by Country, 2021-2030

12.2.1 Saudi Arabia

12.2.2 UAE

12.2.3 Oman

12.2.4 Rest of Middle East

12.2.5 Egypt

12.2.6 Nigeria

12.2.7 South Africa

12.2.8 Rest of Africa

12.3 Middle East and Africa Immunohematology Market size Outlook by Segments, 2021-2030

By Products

Immunohematology Analyzers

Immunohematology Reagents

By Application

Blood Typing

Antibody Screening

By End-User

Hospitals

Diagnostic Laboratories

Others

 

13 Company Profiles

13.1  Company Snapshot

13.2 SWOT Profiles

13.3 Products and Services

13.4 Recent Developments

13.5 Financial Profile

List of Companies

Abbott Laboratories

Beckman Coulter Inc (Danaher Corp)

Becton Dickinson and Company

Bio-Rad Laboratories Inc

Cardinal Health

F. Hoffmann La-Roche Ltd

Grifols S.A.

Immucor Inc

Merck KGaA

Ortho Clinical Diagnostics

Siemens Healthineers

Thermo Fisher Scientific

 

14 Appendix

14.1 Customization Offerings

14.2 Subscription Services

14.3 Related Reports

14.4 Publisher Expertise

Immunohematology Market Segmentation

By Products

Immunohematology Analyzers

Immunohematology Reagents

 

By Application

Blood Typing

Antibody Screening

 

By End-User

Hospitals

Diagnostic Laboratories

Others

 

Geographical Analysis

North America (United States, Canada, Mexico)

Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)

Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)